Clinical Trial Update: Contrast-Enhanced Spectral Mammography (CESM) [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of Contrast-Enhanced Spectral Mammography (CESM) in breast cancer, sponsored by the European Institute of Oncology; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN